Inuspheresis® Treatment in Munich, Germany

What is Inuspheresis®?

• Specialized form of blood purification with over 70,000 procedures performed worldwide.• Uses a patented TKM-58 filter to selectively remove harmful substances from the plasma.• Can target microplastics, spike proteins, heavy metals, immune complexes, and autoantibodies.• Low-risk, well-established procedure with a long track record of efficacy.• Combines multiple benefits of other blood purification methods in a single, comprehensive therapy.

How Does the Procedure Work?

Venous access in both arms - one for inflow, one for outflow.Blood is separated into plasma and cellular components via a plasma filter.Plasma passes through the TKM-58 filter, which removes:
• Microplastics & spike proteins
• Chemicals, toxic metals, pesticides
• Defective proteins, inflammatory mediators, autoantibodiesPurified plasma recombined with blood cells and returned to the body.Procedure duration: ~2 hours, filter can be flushed multiple times.

• Wo We Are & References

Inuspheresis® – Key Applications

1. Improvement of Microcirculation
• Red blood cells must pass through capillaries one at a time; inflammation can make them stick (rouleaux phenomenon).
• Inuspheresis reduces this effect, improving blood flow and vessel health.
• Key markers improved: homocysteine & fibrinogen.2. ME/CFS (Chronic Fatigue Syndrome)
• Study of 1,111 patients (University of Dresden): 74% report being symptom-free or nearly symptom-free after 6 months / 3 treatments.
• Mechanism: reduction of autoantibodies affecting neurotransmitter signaling.
• Supports energy metabolism and nervous system communication.3. Reduction of Microplastics & Hormonal Disruption
• Removes endocrine disruptors from blood, which can impact hormones, metabolism, reproduction, and mood.
• Inuspheresis has been investigated for its potential to reduce microplastics in the blood.
• Ongoing studies explore effects on sperm quality and body composition.4. Effects on Chronic Inflammation & Autoimmune Processes
• Chronic inflammation can reduce quality of life and affect long-term health.
• Inuspheresis is reported to reduce inflammatory markers: sCRP, IL-1 beta, IL-6 (reductions: 33%, 48%, 64%)
• Supports restoration of healthy immune regulation.5. Long COVID & Post-Vaccination Syndromes
• Integrative care for patients with persistent COVID-19-related symptoms.
• Inuspheresis has been studied as a potential supportive therapy